Switching and Discontinuation Pattern of Biologic Disease-Modifying Antirheumatic Drugs and Tofacitinib for Patients With Rheumatoid Arthritis in Taiwan

por Li, Ko-Jen, Chang, Chia-Li, Hsin, Chih-Yi, Tang, Chao-Hsiun
Publicado 2021

Risk for Mycobacterial Disease among Patients with Rheumatoid Arthritis, Taiwan, 2001–2011

por Liao, Tsai-Ling, Lin, Ching-Heng, Shen, Gwan-Han, Chang, Chia-Li, Lin, Chin-Fu, Chen, Der-Yuan
Publicado 2015

Different Risk of Tuberculosis and Efficacy of Isoniazid Prophylaxis in Rheumatoid Arthritis Patients with Biologic Therapy: A Nationwide Retrospective Cohort Study in Taiwan

por Liao, Tsai-Ling, Lin, Ching-Heng, Chen, Yi-Ming, Chang, Chia-Li, Chen, Hsin-Hua, Chen, Der-Yuan
Publicado 2016

Long‐Term Effects of Unprovoked Venous Thromboembolism on Mortality and Major Cardiovascular Events

por Chang, Wei‐Ting, Chang, Chia‐Li, Ho, Chung‐Han, Hong, Chon‐Seng, Wang, Jhi‐Joung, Chen, Zhih‐Cherng
Publicado 2017

Persistence and Adherence to Biologics in Patients with Psoriasis in Taiwan: A New Biologics User Cohort Study

por Huang, Yu-Huei, Tang, Chao-Hsiun, Goh, Choo Hua, Chang, Chia-Li, Qiu, Hong, Yang, Ya-Wen, Saadoun, Carine, Chang, Chia-Ling, Liu, Yanfang
Publicado 2022

Cost-Effectiveness of Sugammadex Versus Neostigmine to Reverse Neuromuscular Blockade in a University Hospital in Taiwan: A Propensity Score-Matched Analysis

por Lan, Winnie, Tam, Ka-Wai, Chen, Jui-Tai, Cata, Juan P., Cherng, Yih-Giun, Chou, Yun-Yun, Chien, Li-Nien, Chang, Chia-Li, Tai, Ying-Hsuan, Chu, Lu-Min
Publicado 2023